High-definition transcranial direct current stimulation desynchronizes refractory status epilepticus.

Area of Science:

• Neuroscience
• Neurology
• Biomedical Engineering

Background:

• Refractory status epilepticus (RSE) presents a significant clinical challenge with limited treatment options.
• Previous research demonstrated that high-definition transcranial direct current stimulation (hd-tDCS) can acutely reduce epileptic spike rates in RSE patients.
• A potential mechanism for hd-tDCS efficacy involves modulation of electroencephalographic (EEG) activity, specifically desynchronization.

Purpose of the Study:

• To investigate whether EEG desynchronization during hd-tDCS correlates with its observed anti-epileptic effects in RSE.
• To analyze changes in EEG power spectrum across different frequency bands during and after hd-tDCS in RSE patients.

Main Methods:

• EEG data from 27 sessions in 10 RSE patients undergoing 20-minute hd-tDCS (2 mA) targeted at the epileptic focus were analyzed.
• EEG desynchronization was defined as increased power in higher frequencies (gamma, >30 Hz) and decreased power in lower frequencies (<30 Hz).
• Relative power changes in delta, theta, alpha, beta, and gamma bands were assessed during and after stimulation using bipolar longitudinal and referential Laplacian montages.

Main Results:

• During hd-tDCS, significant increases in relative gamma power (+4.84% to +5.41%) and decreases in delta, theta, alpha, and beta power were observed across both montages (p < 0.002).
• Post-stimulation, these power changes reversed, with significant decreases in gamma power (-4.68% to -5.12%) and increases in lower frequencies.
• The observed EEG desynchronization pattern during stimulation is consistent with the anti-epileptic effects of hd-tDCS.

Conclusions:

• EEG desynchronization, characterized by a shift towards higher frequencies (gamma) and away from lower frequencies during stimulation, is a key mechanism underlying hd-tDCS efficacy in RSE.
• These findings support hd-tDCS as a promising, non-invasive therapeutic option for managing refractory status epilepticus.
• Further research is warranted to optimize hd-tDCS parameters for enhanced anti-epileptic outcomes.